Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder
Nordic Journal of Psychiatry · 2026
DOI: 10.1080/08039488.2025.2590578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nordic Journal of Psychiatry, 2026. Verfasst von Jonna Levola und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Hospital District of Helsinki and Uusimaa, Helsinki, Finland. Hauptthemen laut MEDLINE: Clozapine, Schizophrenia, Smoking, Antipsychotic Agents. Die Arbeit nennt 32 Literaturangaben. Gefördert von: The Alcohol Research Foundation, Hospital District of Helsinki and Uusimaa, Hyvinkää Hospital Area.
Abstract (Originalsprache)
PURPOSE: Alcohol use and daily smoking are common among individuals with schizophrenia spectrum disorder but less is known about their relationship to psychotic symptom profile and severity, and how clozapine use may affect this relationship. MATERIALS AND METHODS: Among a clinical sample of 276 Finnish outpatients with schizophrenia spectrum disorder (68.8% schizophrenia), the Brief Psychiatric Rating Scale (BPRS) and the Scale for the Assessment of Negative Symptoms (SANS) were used to determine severity of psychotic symptoms. Information regarding alcohol use was collected with questionnaires including the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) and information of smoking. Associations between psychiatric symptoms and substance use were studied using linear regression separately for those with or without clozapine use. Age, gender, marital status, living situation and education were adjusted for in the final analyses. RESULTS: In the multivariable models, heavy alcohol use and binge drinking were less frequent among participants with clozapine use (n = 115) compared to those without (n = 161). Differences in some symptoms were observed in bivariate analyses when comparing the participants with and without heavy or binge drinking, or daily smoking. Heavy and binge drinking were associated with more severe grandiosity symptoms even after controlling for potential confounders. Daily smoking was associated with more severe hostility, elated mood, unusual thought content and uncooperativeness, but less severe emotional withdrawal. CONCLUSIONS: Symptom profiles and severity differed according to alcohol use or smoking. The possible explanations for the role of clozapine are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Hospital District of Helsinki and Uusimaa, Helsinki, Finland.
- Department of Psychiatry, University of Helsinki, Helsinki, Finland.
- Department of Psychiatry, University of Turku, Turku, Finland.
- Addiction Psychiatry Unit, Turku University Hospital, Turku, Finland.
- Department of Healthcare and Social Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
ORCID-Profile: Jonna Levola, Sari Lång-Tonteri, Solja Niemelä, Jaana Suvisaari, Saana Eskelinen
Förderung
- The Alcohol Research Foundation
- Hospital District of Helsinki and Uusimaa
- Hyvinkää Hospital Area
- Lundbeck Inc.
- Finnish Foundation for Psychiatric Research
- Finnish Medical Foundation
Zitieren
APA
Levola, J., Lång-Tonteri, S., Niemelä, S., Suvisaari, J., & Eskelinen, S. (2026). Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder. Nordic Journal of Psychiatry. https://doi.org/10.1080/08039488.2025.2590578
Vancouver
Levola J, Lång-Tonteri S, Niemelä S, Suvisaari J, Eskelinen S. Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder. Nordic Journal of Psychiatry. 2026. doi:10.1080/08039488.2025.2590578
BibTeX
@article{Levola2026,
author = {Levola, Jonna and Lång-Tonteri, Sari and Niemelä, Solja and Suvisaari, Jaana and Eskelinen, Saana},
title = {Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder},
journal = {Nordic Journal of Psychiatry},
year = {2026},
doi = {10.1080/08039488.2025.2590578}
}
EUVIMED